Evidence map›Paper›PMID 26306784›Full record

ArticleCellular oncology (Dordrecht, Netherlands)2015

Prognostic value of cytokeratin-7 mRNA expression in peripheral whole blood of advanced lung adenocarcinoma patients.

Ana Koren, Eva Sodja, Matija Rijavec, Mojca Jez, Viljem Kovac, Peter Korosec, Tanja Cufer

Abstract read
In one paragraph

Article in Cellular oncology (Dordrecht, Netherlands), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ana KorenUniversity Clinic Golnik, Golnik 36, 4204, Golnik, Slovenia. ana.koren@klinika-golnik.si.
Eva SodjaUniversity Clinic Golnik, Golnik 36, 4204, Golnik, Slovenia.
Matija RijavecUniversity Clinic Golnik, Golnik 36, 4204, Golnik, Slovenia.
Mojca JezBlood Transfusion Centre of Slovenia, Slajmerjeva 6, 1000, Ljubljana, Slovenia.
Viljem KovacInstitute of Oncology Ljubljana, Zaloska cesta 2, 1000, Ljubljana, Slovenia.
Peter KorosecUniversity Clinic Golnik, Golnik 36, 4204, Golnik, Slovenia.
Tanja CuferUniversity Clinic Golnik, Golnik 36, 4204, Golnik, Slovenia.
University Clinic of Pulmonary and Allergic Diseases Golnik · SIBlood Transfusion Centre of Slovenia · SIInstitute of Oncology Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe rarity of circulating tumour cells (CTCs) in peripheral blood requires the application of sensitive techniques for their detection. The aim of our study was to (i) first determine the sensitivity of cytokeratin-7 (KRT7) mRNA expression levels for the molecular detection of CTCs using spiked-in lung adenocarcinoma (AC)-derived A549 cells and (ii) evaluate the impact of KRT7 mRNA expression in peripheral whole blood on the response to treatment and prognosis of patients with advanced lung AC who were treated with first-line platinum-based chemotherapy.

methodsA549 cells were micro-manipulated before being spiked into whole blood samples obtained from healthy donors. Additionally, whole blood samples from 65 lung AC patients were collected in PAXgene blood tubes before the start of first-line platinum-based chemotherapy. KRT7 mRNA expression was measured using RT-qPCR.

resultsThrough the spike-in experiment we found that it is feasible to detect a single A549 tumour cell in 2.5 ml whole blood and that the KRT7 mRNA levels were linearly correlated with the number of spiked-in tumour cells with a high reproducibility. In lung AC patients, no significant differences in response rate to chemotherapy, progression-free survival or overall survival and KRT7 mRNA levels were found.

conclusionsOur data show that KRT7 mRNA expression measured by RT-qPCR serves as a sensitive approach for the molecular detection of KRT7-positive CTC-resembling A549 cells in peripheral whole blood. The KRT7 mRNA levels measured were not significantly associated with the response to chemotherapy or the survival of patients with advanced lung AC. Additional studies are required to establish the possible clinical significance of KRT7 mRNA expression in whole blood after chemotherapy.

Indexed as

AdenocarcinomaAdultAgedAntineoplastic Combined Chemotherapy ProtocolsCell Line, TumorFemaleHumansKaplan-Meier EstimateKeratin-7Lung NeoplasmsMaleMiddle AgedNeoplastic Cells, CirculatingPrognosisReverse Transcriptase Polymerase Chain ReactionRNA, MessengerKeratin-7RNA, MessengerCirculating tumour cellsKRT7Lung adenocarcinomamRNA expressionPrognosis

Identifiers

PMID26306784
PMCPMC13004177
OpenAlexW2117681170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.